Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ulcerative colitis (UC). The primary ...
Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...
Calgary Herald on MSN2d
What to know about measles outbreaks and why they're happeningMeasles is on the rise and one expert warns it’s only beginning. As of Thursday, the province has confirmed 14 cases of the ...
Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...
Multiple myeloma is a type of cancer characterized by the uncontrolled proliferation of clonal plasma cells, which leads to ...
Zacks Investment Research on MSN6d
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...
Earlier diagnosis of Alzheimer’s disease is seen as increasingly important and worthwhile as a focus for new medications ... safety in phase 1/2 studies in combination with Keytruda ...
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of ...
Unlock the latest advancements in obesity treatment. Expert insights reveal groundbreaking medical breakthroughs and ...
CHWs bridge gaps in asthma care for Black children. Study shows promise in improving outcomes & clinical trial participation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback